• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

HIV (Human Immunodeficiency Virus) - Articles and news items

global hiv treatment

Global dual-drug trial aims to advance HIV treatment

Industry news / 16 August 2016 / ViiV Healthcare

ViiV Healthcare is undertaking two identical studies as part of a global phase III programme comparing a two-drug regimen of dolutegravir plus lamivudine, with a three-drug regimen of dolutegravir (Tivicay), plus the fixed-dose tablet tenofovir/emtricitabine (Truvada), to support regulatory filings as a treatment for HIV, for adults who have had no prior antiretroviral therapy…


Triumeq demonstrates superior efficacy for treating women with HIV

Industry news / 19 July 2016 / Victoria White, Digital Content Producer

Triumeq demonstrated superior efficacy compared with ATV/r plus TDF/FTC in 495 treatment-naïve women living with HIV…


EC grants marketing authorisation to Odefsey in HIV

Industry news / 23 June 2016 / Victoria White, Digital Content Producer

The EC has granted marketing authorisation for Gilead’s once-daily single tablet regimen Odefsey for the treatment of HIV-1 infection in certain patients…


3BNC117 opens door to potential new treatment for HIV

Industry news / 9 May 2016 / Victoria White, Digital Content Producer

Researchers are developing a new kind of treatment, an antibody-based drug called 3BNC117, that may provide a better strategy for long-term control of HIV…


From HIV to oncology: widening access through flexible IP

Blog, Z Homepage promo / 28 April 2016 / Jon Pender, VP Government Affairs, GSK

Jon Pender, GSK, discusses how a flexible and thoughtful approach to IP can help get medicines to the poorest and hardest-to-reach patients around the world…


EC grants marketing authorisation for two doses of Gilead’s Descovy

Industry news / 25 April 2016 / Victoria White, Digital Content Producer

Descovy is the first new HIV backbone approved in Europe in more than a decade and represents an important advance in addressing the needs of patients…


Combined HIV and hepatitis C virus vaccination a step closer

Industry news / 13 April 2016 / Victoria White, Digital Content Producer

A study has shown that the ‘prime boost’ approach is compatible with co-administration of vectors encoding for HIV and HCV antigens…


Enrolment begins in trials of investigational anti-HIV antibody VRC01

Industry news / 7 April 2016 / Victoria White, Digital Content Producer

Enrolment has started for two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection, VRC01…


NHS England to fund HIV treatment Rezolsta (darunavir/cobicistat)

Industry news / 30 March 2016 / Victoria White

Darunavir/cobicistat is indicated for use in combination with other antiretroviral medications, for treating adults with HIV-1…


Janssen announces results from its ongoing LATTE-2 study

Industry news / 26 February 2016 / Victoria White

The LATTE-2 study showed that a regimen of two investigational long-acting, intramuscular (IM) formulations of HIV medicines had comparable antiviral activity to 3-drug oral antiretroviral therapy in HIV-1 infected adults…


CHMP adopts positive opinion of Gilead’s Descovy

Industry news / 26 February 2016 / Victoria White

Descovy is an investigational fixed-dose combination for the treatment of HIV-1 infection in adults and adolescents in combination with other HIV antiretroviral agents…


Gilead announces results from study evaluating switching to F/TAF-based regimens from Truvada

Industry news / 24 February 2016 / Victoria White

At Week 48 of the study, the F/TAF-based regimens were found to be statistically non-inferior to the F/TDF-based regimens in HIV-1 infected adult patients…


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +